Showing results (311-320 of 346) with videos related to

Sort By:
Pageof 35
The International Journal of Neuroscience|December 1, 1991
Risk factors for neuroleptic-induced movement disordersR Sandyk, S R Kay, G I Awerbuch, et al.
The International Journal of Neuroscience|August 1, 1987
Clonidine in neuropsychiatric disorders: a reviewR Sandyk, M A Gillman, R P Iacono, et al.
Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.
Life Sciences|July 1, 1985
Active and inactive L-prolyl-L-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's diseaseT C Case, S R Snider, V J Hruby, et al.
European Neurology|January 1, 1991
Relapsing lumbosacral plexus neuropathy. Report of two casesG I Awerbuch, M A Nigro, R Sandyk, et al.
Medical Hypotheses|September 1, 1991
Deranged modulatory midbrain opioid and gonadotrophin functions: relevance to Tourette's syndromeR Sandyk, G Awerbuch, P F Kwo-On-Yuen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.
Functional Neurology|July 1, 1987
Post-amputation phantom pain and autonomous stump movements responsive to doxepinR P Iacono, R Sandyk, C R Bamford, et al.
Neurology|August 1, 1979
The role of bromocriptine in the treatment of parkinsonismS Fahn, L J Cote, S R Snider, et al.
Pageof 35